Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.130 GeneticVariation disease BEFREE Genomic DNA of the siblings affected by FH with biopsy‑proven FSGS was analyzed, and their father was screened for 18 gene mutations associated with FSGS [nephrin, podocin, CD2 associated protein, phospholipase C ε, actinin α 4, transient receptor potential cation channel subfamily C member 6, inverted formin, FH2 and WH2 domain containing, Wilms tumor 1, LIM homeobox transcription factor 1 β, laminin subunit β 2, laminin subunit β 3, galactosida α, integrin subunit β 4, scavenger receptor class B member 2, coenzyme Q2, decaprenyl diphosphate synthase subunit 2, mitochondrially encoded tRNA leucine 1 (UUA/G; TRNL1) and SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1] using matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry technology. 29138824 2018
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.130 Biomarker disease BEFREE We conclude that increased Wnt and Notch activity result from SMARCAL1 deficiency and, as established causes of FSGS, contribute to the renal disease of most SIOD patients. 27816064 2016
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.130 Biomarker disease BEFREE To better understand the role of SMARCAL1 in the pathogenesis of FSGS, we defined SMARCAL1 expression in the developing and mature kidney. 25319549 2015
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.130 CausalMutation disease CLINVAR
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.130 Biomarker disease HPO